Halozyme Therapeutics Stock (NASDAQ: HALO)

Halozyme Therapeutics (NASDAQ:HALO) Stock, Unusual Options

Halozyme Therapeutics

Halozyme Therapeutics, Inc. - Common Stock

Overview

News

Earnings

Options

Guidance

Analyst Ratings

Insider Trades

Short Interest

Government Trades

Stock Report

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Comments

Halozyme Therapeutics Unusual Options